NASDAQ$WBA

Walgreens Boots Alliance Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Walgreens Boots Alliance reported Q2 fiscal 2025 sales of $38.6B with a net loss of $2.85B and diluted EPS of $(3.30).

Sales were $38.59 billion but goodwill impairment and U.S. retail challenges drove a net loss of $2.85 billion, or $(3.30) per diluted share.

  • Q2 sales $38.59B.
  • Net loss $2.85B; diluted EPS $(3.30).
  • U.S. retail and pharmacy trends.
  • Transformation and cost actions in MD&A.

Headline financials

Total Revenue

$38.6B

Previous: $37.1B+4.1%
EPS (adj)

-$3.30

Previous: $1.20-375.0%
Prescriptions filled

309.0M

Previous: 305.3M+1.2%
Capital Expenditures

-$219M

Previous: -$352M+37.8%
Net Income

-$2.85B

Previous: -$5.91B+51.7%
Operating Income

-$5.57B

Previous: -$13.2B+57.7%
Gross Profit

$6.94B

Previous: $7.04B-1.5%
R&D Expense

$0.00

No prior period

Revenue & EPS history

Walgreens · Revenue · Quarterly

$38.6B

Q2 2025+4.1%vs Q2 2024
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

Walgreens · $7.76B total across 2 segments · Q4 2023

  • International
    $5.78B
  • U.S. Healthcare
    $1.97B+217.0%

Forward guidance

Outlook emphasizes path to profitability, liquidity, and cost discipline.

Tailwinds

  • Operating initiatives and balance-sheet flexibility.
  • Segment turnaround actions noted in MD&A.

Headwinds

  • Operating losses and macro demand uncertainty.
  • Financing or impairment risks.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 16 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-1.9%

Avg return

30 days after

53%

33 / 62 earnings

Positive

+29.1%

Q1 2025

Best reaction

-22.7%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025+0.4%+1.5%+2.7%
Q2 2025-1.1%+0.5%+4.1%
Q1 2025+29.1%+36.1%+10.0%
Q4 2024+23.0%+18.7%-2.0%
Q3 2024-22.7%-26.0%-24.5%
Q2 2024-7.0%-10.9%-15.7%
Q1 2024-2.2%-0.6%-11.4%
Q4 2023+2.9%+2.1%-7.3%
Q3 2023-7.9%-10.2%-3.0%
Q2 2023+3.7%+5.0%+6.6%
Q1 2023-2.3%-2.1%-1.1%
Q4 2022+4.1%+3.8%+29.4%
Q3 2022-5.7%-5.7%-2.9%
Q2 2022-7.6%-8.4%-10.6%
Q1 2022-0.3%+0.6%-10.0%
Q4 2021+3.5%+1.5%+4.8%
Q3 2021-8.4%
Q2 2021+3.3%
Q1 2021+5.1%
Q4 2020+4.2%
Q3 2020-5.1%
Q2 2020-5.4%
Q1 2020-7.8%
Q4 2019+1.5%
Q3 2019+4.4%
Q2 2019-13.6%
Q1 2019-8.2%
Q4 2018+1.6%
Q3 2018-9.4%
Q2 2018-0.7%
Q1 2018-3.4%
Q4 2017-0.3%
Q3 2017+1.6%
Q2 2017-1.0%
Q1 2017+0.1%
Q4 2016+5.7%
Q3 2016-3.6%
Q2 2016-3.0%
Q1 2016+1.8%
Q4 2015-11.9%
Q3 2015+8.4%
Q1 2014+4.9%
Q2 2015+4.9%
Q4 2013+4.9%
Q1 2015+3.2%
Q4 2014-0.9%
Q3 2014+0.6%
Q2 2014+1.0%
Q3 2013-1.0%
Q2 2013+0.4%
Q1 2013+1.6%
Q4 2012+1.4%
Q3 2012-3.2%
Q2 2012-1.9%
Q1 2012+4.1%
Q4 2011+0.4%
Q3 2011-0.9%
Q2 2011+1.8%
Q1 2010+2.5%
Q4 2010+1.8%
Q3 2010-0.1%
Q2 2009+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro